Therapeutic Asset Ratings

6,369 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
IMMUNOGLOBULIN G2, ANTI-(HUMAN CTLA-4 (ANTIGEN)) (HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 HEAVY CHAIN) DISULPHIDE WITH HUMAN MONOCLONAL CP-675206 CLONE 11.2.1 LIGHT CHAIN, DIMER Ovarian Carcinoma	National Cancer Institute (NCI)	P2	B (63)
IMMUNOGLOBULIN G4, ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL REGN2810 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL REGN2810 .KAPPA.-CHAIN, DIMER Plasma Cell Myeloma	Sanofi	P2	B (63)
Infliximab Colitis	Therakos LLC	P2	B (63)
Ipilimumab Rectal Cancer	Odense University Hospital	P2	B (63)
Ipilimumab Head And Neck Squamous Cell Carcinoma	Neonc Technologies, Inc.	P2	B (63)
Ipilimumab Neuroblastoma	Children's National Research Institute	P2	B (63)
Nivolumab Castration-Resistant Prostate Carcinoma	Rana McKay, MD	P2	B (63)
Nivolumab Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8	Fred Hutchinson Cancer Center	P2	B (63)
Nivolumab Colorectal Adenocarcinoma	University Hospital, Akershus	P2	B (63)
Nivolumab Colorectal Carcinoma	Fred Hutchinson Cancer Center	P2	B (63)
Nivolumab Fibrolamellar Hepatocellular Carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	B (63)
Nivolumab Her2-Receptor Negative Breast Cancer	Fred Hutchinson Cancer Center	P2	B (63)
Nivolumab Ovarian Serous Adenocarcinoma	pharmaand GmbH	P2	B (63)
Nivolumab Lung Carcinoma	M.D. Anderson Cancer Center	P2	B (63)
Nivolumab Metastatic Neoplasm	Mohammed Milhem	P2	B (63)
Nivolumab Skin Basal Cell Carcinoma	Fred Hutchinson Cancer Center	P2	B (63)
Nivolumab Rectum Adenocarcinoma	National Cancer Institute (NCI)	P2	B (63)
Nivolumab Skin Squamous Cell Carcinoma	Fred Hutchinson Cancer Center	P2	B (63)
Nivolumab Nivolumab	M.D. Anderson Cancer Center	P2	B (63)
Nivolumab Pancreatic Neoplasm	Orion Corporation, Orion Pharma	P2	B (63)
Nivolumab Peripheral T-Cell Lymphoma, Not Otherwise Specified	University of Michigan Rogel Cancer Center	P2	B (63)
Nivolumab B-Cell Acute Lymphoblastic Leukemia	Assistance Publique - Hôpitaux de Paris	P2	B (63)
Nivolumab Urinary Bladder Cancer	M.D. Anderson Cancer Center	P2	B (63)
Nivolumab Rectal Cancer	Odense University Hospital	P2	B (63)
Nivolumab Stage IVb Bladder Cancer	M.D. Anderson Cancer Center	P2	B (63)

Showing 626 to 650 of 6,369 assets

PreviousPage 26 of 255Next